Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TBC1D17 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
mRNA | TMEM238 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
mRNA | FERMT2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
mRNA | UBE2D2 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
mRNA | CDK10 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
mRNA | RP11-385D13.1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
mRNA | BFSP1 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
mRNA | BEND3 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
mRNA | TMTC1 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
mRNA | FAM219A | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |